0001947620-22-000002.txt : 20221018 0001947620-22-000002.hdr.sgml : 20221018 20221018120708 ACCESSION NUMBER: 0001947620-22-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221018 DATE AS OF CHANGE: 20221018 EFFECTIVENESS DATE: 20221018 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lapix Therapeutics Inc. CENTRAL INDEX KEY: 0001947620 IRS NUMBER: 842410144 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-462080 FILM NUMBER: 221315439 BUSINESS ADDRESS: STREET 1: 75 KNEELAND STREET STREET 2: 14TH FLOOR CITY: BOSTON STATE: MA ZIP: 02111 BUSINESS PHONE: 1 (617) 766-3909 MAIL ADDRESS: STREET 1: 75 KNEELAND STREET STREET 2: 14TH FLOOR CITY: BOSTON STATE: MA ZIP: 02111 D 1 primary_doc.xml X0708 D LIVE 0001947620 Lapix Therapeutics Inc. 75 KNEELAND STREET 14TH FLOOR BOSTON MA MASSACHUSETTS 02111 1 (617) 766-3909 DELAWARE Pstology Inc. None Corporation true 2019 Anas Fathallah c/o Lapix Therapeutics, Inc. 14 Kneeland St., 14th Floor Boston MA MASSACHUSETTS 02111 Executive Officer Director Jason Norris c/o Lapix Therapeutics, Inc. 14 Kneeland St., 14th Floor Boston MA MASSACHUSETTS 02111 Executive Officer Director Other Technology Decline to Disclose 06b false 2022-08-29 false true Simple Agreements for Future Equity false 0 1500000 1247500 252500 false 7 0 0 0 true false Lapix Therapeutics Inc. Anas Fathallah Anas Fathallah President 2022-10-18